PPD has significant experience in conducting Phase I-IV respiratory clinical trials, ranging from a single protocol to full development programs with multiple protocols running concurrently. In the past five years, we conducted more than 170 studies in respiratory indications involving more than 45,000 patients at more than 5,600 sites.
PPD’s global investigator database contains more than 2,500 investigators with expertise in the respiratory therapeutic area. Also, our team of experienced biostatisticians, clinical managers, clinical research associates (CRAs), data managers, medical staff and project managers is well-versed in managing and monitoring the procedures associated with objectives and end points used in many respiratory protocols.
We have strong relationships with clinical investigators and key opinion leaders, and our expertise enables us to provide rapid feasibility and consulting services on a wide variety of respiratory protocol concepts and designs. As a result, our pharmaceutical and biotech clients can make decisions quickly and move their development programs forward at a rapid pace.
Respiratory Clinical Research Experience
PPD has managed respiratory studies for various disease states, including:
- Acute and chronic sinusitis
- Allergic rhinitis (seasonal and perennial)
- Asthma (mild to severe)
- Chronic obstructive pulmonary disease (COPD)
- Cystic fibrosis
- Idiopathic pulmonary fibrosis
- Malignant neoplasm of trachea, bronchus and lung
- Other diseases of lung and respiratory system